Kijima-Suda I, Miyamoto Y, Toyoshima S, Itoh M, Osawa T
Cancer Res. 1986 Feb;46(2):858-62.
The total and sialidase-releasable sialic acid contents of murine colon adenocarcinoma 26 sublines of high (NL-17) and low (NL-44) metastatic potential were found to be positively correlated with their ability to undergo metastasis. Furthermore, sialyltransferase activity of intact NL-17 cells was higher than that of NL-44 cells. These findings suggest that sialic acid on the cell surface may play a role in the metastasis of these cells. Therefore, the effect of a sialyltransferase inhibitor, 5-fluoro-2',3'-isopropylidene-5'-O-(4-N-acetyl-2,4-dideoxy-3,6,7,8-tetra -O -acetyl-1-methoxycarbonyl-D-glycero-alpha-D-galactooctapyranosyl)u ridine (Kl-8110), on the experimental lung metastasis of NL-17 or NL-44 cells was examined. Kl-8110 inhibited the transfer of sialic acid to its endogenous acceptor in NL-17 and NL-44 cells. NL-17 or NL-44 cells were injected into the tail veins of mice, and the metastasis-inhibiting activity of Kl-8110 was evaluated on the basis of both the lung weight and the number of pulmonary surface nodules about 3 wk after the tumor cell injection and of the survival ratio of mice inoculated with the tumor cells. Pretreatment of tumor cells with Kl-8110 together with i.v. injection of Kl-8110 caused significant inhibition of pulmonary metastasis of both NL-17 and NL-44 cells. Inhibition of metastasis and prolongation of survival were also observed on i.v. injection of Kl-8110 without pretreatment of the tumor cells with Kl-8110, but the degree of inhibition was lower than that in the case of the two treatments together. Kl-8110 itself had neither cytostatic nor cytotoxic effects on NL-17 and NL-44 but reduced the retention of tumor cells in the lungs. This antimetastatic effect of Kl-8110 may be due to modification of the tumor cell surface resulting from inhibition of sialyltransferase by Kl-8110. In addition, a beta-linked sialic acid:nucleoside conjugate (Kl-8111) and an equimolar mixture of Kl-8110 and Kl-8111 (Kl-414) also inhibited the metastatic ability of NL cells to the same extent as Kl-8110 did.
研究发现,具有高转移潜能(NL-17)和低转移潜能(NL-44)的小鼠结肠腺癌26亚系的总唾液酸含量和唾液酸酶可释放唾液酸含量与它们的转移能力呈正相关。此外,完整的NL-17细胞的唾液酸转移酶活性高于NL-44细胞。这些发现表明,细胞表面的唾液酸可能在这些细胞的转移中起作用。因此,研究了唾液酸转移酶抑制剂5-氟-2',3'-异亚丙基-5'-O-(4-N-乙酰基-2,4-二脱氧-3,6,7,8-四-O-乙酰基-1-甲氧基羰基-D-甘油-α-D-半乳糖辛吡喃糖基)尿苷(Kl-8110)对NL-17或NL-44细胞实验性肺转移的影响。Kl-8110抑制了NL-17和NL-44细胞中唾液酸向其内源性受体的转移。将NL-17或NL-44细胞注入小鼠尾静脉,并在肿瘤细胞注射后约3周根据肺重量、肺表面结节数量以及接种肿瘤细胞的小鼠存活率评估Kl-8110的转移抑制活性。用Kl-8110预处理肿瘤细胞并静脉注射Kl-8110可显著抑制NL-17和NL-44细胞的肺转移。在未用Kl-8110预处理肿瘤细胞的情况下静脉注射Kl-8110也观察到转移抑制和存活延长,但抑制程度低于两种处理同时进行的情况。Kl-8110本身对NL-17和NL-44既没有细胞抑制作用也没有细胞毒性作用,但减少了肿瘤细胞在肺中的滞留。Kl-8110的这种抗转移作用可能是由于Kl-8110抑制唾液酸转移酶导致肿瘤细胞表面发生改变。此外,β-连接的唾液酸:核苷缀合物(Kl-8111)以及Kl-8110和Kl-8111的等摩尔混合物(Kl-414)也与Kl-8110一样程度地抑制NL细胞的转移能力。